Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Addex Therapeutics Ltd    ADXN   CH0029850754

End-of-day quote. End-of-day quote  - 02/12
2.68 CHF   +0.75%
01/11 ADDEX THERAPEUT : Dipraglurant Shows Highly Statistically Significan..
01/04 ADDEX THERAPEUT : ' Dipraglurant Receives Orphan Drug Designation fr..
2015 ADDEX THERAPEUT : Reports Statistically Significant Positive Interim..
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Swiss Exchange
02/08/2016 02/09/2016 02/10/2016 02/11/2016 02/12/2016 Date
2.93(c) 2.76(c) 2.8(c) 2.66(c) 2.68(c) Last
19 151 23 039 13 201 69 845 21 073 Volume
-2.33% -5.80% +1.45% -5.00% +0.75% Change
More quotes
Company
Addex Therapeutics Ltd. engages in the discovery and development of oral small molecule drugs.The company uses its proprietary discovery platform to address receptors and other proteins that are undruggable for conventional drug discovery methods, including G-protein coupled receptors, receptor... 
More about the company
Latest news on ADDEX THERAPEUTICS LTD
01/11 ADDEX THERAPEUTICS : Dipraglurant Shows Highly Statistically Significant Anti-Dy..
01/04 ADDEX THERAPEUTICS : ' Dipraglurant Receives Orphan Drug Designation from the FD..
2015 ADDEX THERAPEUTICS : Reports Statistically Significant Positive Interim Data for..
2015 ADDEX THERAPEUTICS : and University of Geneva Collaborators Awarded Swiss Grant ..
2015 ADDEX THERAPEUTICS : Scientists Publish New Data Supporting the Potential of mGl..
2015 ADDEX THERAPEUTICS : Moves R&D Operations to Geneva’s Campus Biotech
2015 ADDEX THERAPEUTICS : Moves R&D Operations to Geneva's Campus Biotech
2015 ADDEX THERAPEUTICS : ADX71441 Included in the NINDS Anticonvulsant Screening Pro..
More news
Sector news : Biotechnology & Medical Research - NEC
08:52a AMGEN : Kyprolis launches in the UK for relapsed multiple myeloma
02/11 LONZA : Education Great Bay, UNH Manchester offer biotech program Department of ..
02/11 FDA panel recommends approval for copy of arthritis drug Remicade
More sector news : Biotechnology & Medical Research - NEC


Comments 
Advertisement
Chart ADDEX THERAPEUTICS LTD
Duration : Period :
Addex Therapeutics Ltd Technical Analysis Chart | ADXN | CH0029850754 | 4-Traders
Full-screen chart
Technical analysis trends ADDEX THERAPEUTIC...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials